Association Between Quality of Life Defined by EuroQol Group 5 Dimension and Composite Inferior Outcome Among Inpatients with Cirrhosis

References

• Sheena BS, Hiebert L, Han H.; Collaborators GBDHB. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796–829. doi:10.1016/S2468-1253(22)00124-8
   PubMed Web of Science ®Google Scholar
• Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Jepsen P, Younossi ZM. The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs. J Hepatol. 2021;75 Suppl 1:S3–S13. doi:10.1016/j.jhep.2020.11.042
   PubMed Web of Science ®Google Scholar
• Wang X, Luo JN, Wu XY, Zhang QX, Wu B. Study of liver cirrhosis over twenty consecutive years in adults in Southern China. World J Hepatol. 2023;15(12):1294–1306. doi:10.4254/wjh.v15.i12.1294
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang J, Huang J, Sun W, Wang J, Chen D. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. Clinics. 2015;70(8):563–568. doi:10.6061/clinics/2015(08)06
   PubMed Web of Science ®Google Scholar
• Wang X, Liu H, Qi J, et al. Trends of mortality in end-stage liver disease - China. China CDC Wkly. 2023;5(30):657–663. doi:10.46234/ccdcw2023.128
   PubMedGoogle Scholar
• Enomoto H, Ueno Y, Hiasa Y, et al. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2020;55(3):353–362. doi:10.1007/s00535-019-01645-y
   PubMed Web of Science ®Google Scholar
• Desai AP, Mohan P, Nokes B, et al. Increasing economic burden in hospitalized patients with cirrhosis: analysis of a national database. Clin Transl Gastroenterol. 2019;10(7):e00062. doi:10.14309/ctg.0000000000000062
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96(7):2199–2205. doi:10.1111/j.1572-0241.2001.03956.x
   PubMed Web of Science ®Google Scholar
• Tapper EB, Kanwal F, Asrani SK, et al. Patient-reported outcomes in cirrhosis: a scoping review of the literature. Hepatology. 2018;67(6):2375–2383. doi:10.1002/hep.29756
   PubMed Web of Science ®Google Scholar
• Orr JG, Homer T, Ternent L, et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61(5):1158–1165. doi:10.1016/j.jhep.2014.06.034
   PubMed Web of Science ®Google Scholar
• Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford University Press; 2017:348.
   Google Scholar
• Kimbell B, Murray SA, Byrne H, et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018;32(5):919–929. doi:10.1177/0269216318760441
   PubMed Web of Science ®Google Scholar
• Wu X, Hong J, Zhou J, et al. Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis. Hepatol Int. 2021;15(6):1318–1327. doi:10.1007/s12072-021-10240-4
   PubMed Web of Science ®Google Scholar
• Younossi Z, Aggarwal P, Shrestha I, et al. The burden of non-alcoholic steatohepatitis: a systematic review of health-related quality of life and patient-reported outcomes. JHEP Rep. 2022;4(9):100525. doi:10.1016/j.jhepr.2022.100525
   PubMedGoogle Scholar
• Skladany L, Liska D, Liptakova E, Tapajcikova T, Vnencakova J, Koller T. Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia. Sci Rep. 2023;13(1):2463. doi:10.1038/s41598-023-29510-2
   PubMed Web of Science ®Google Scholar
• Rajpurohit S, Musunuri B, Mohan PB, Bhat G, Shetty S. Factors affecting and promoting health-related quality of life in patients with liver cirrhosis: an underestimated domain in patient care. J Clin Exp Hepatol. 2024;14(1):101264. doi:10.1016/j.jceh.2023.07.417
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kedarisetty CK, Abbas Z, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8(4):453–471. doi:10.1007/s12072-014-9580-2
   PubMed Web of Science ®Google Scholar
• Moore KP. The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology. 2003;38(1):258–266. doi:10.1053/jhep.2003.50315
   PubMed Web of Science ®Google Scholar
• American Association for the Study of Liver D. European Association for the Study of the l. hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61(3):642–659. doi:10.1016/j.jhep.2014.05.042
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–335. doi:10.1002/hep.28906
   PubMed Web of Science ®Google Scholar
• Kok B, Whitlock R, Ferguson T, et al. Health-related quality of life: a rapid predictor of hospitalization in patients with cirrhosis. Am J Gastroenterol Apr. 2020;115(4):575–583. doi:10.14309/ajg.0000000000000545
   PubMed Web of Science ®Google Scholar
• EuroQol G. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341–353. doi:10.1002/hec.673
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Belayachi J, El Khattate A, Bizrane M, Madani N, Abouqal R. Pre-admission quality of life as predictor of outcome after acute care: the role of emotional well-being. QJM. 2018;111(2):111–115. doi:10.1093/qjmed/hcx209
   PubMed Web of Science ®Google Scholar
• Xu X, Zhu Y, Li S, Xia D. Dietary intake of anthocyanidins and renal cancer risk: a prospective study. Cancers. 2023;15(5):1406. doi:10.3390/cancers15051406
   PubMed Web of Science ®Google Scholar
• Rogal SS, Hansen L, Patel A, et al. AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76(3):819–853. doi:10.1002/hep.32378
   PubMed Web of Science ®Google Scholar
• Foster C, Baki J, Nikirk S, Williams S, Parikh ND, Tapper EB. Comprehensive health-state utilities in contemporary patients with cirrhosis. Hepatol Commun. 2020;4(6):852–858. doi:10.1002/hep4.1512
   PubMed Web of Science ®Google Scholar
• Patel AA, Tapper EB, Kanwal F, et al. Targets and study design for symptom-focused trials aimed at patients with cirrhosis: an expert consensus. Hepatol Commun. 2023;7(6):doi:10.1097/HC9.0000000000000135
   Web of Science ®Google Scholar
• Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an nih roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–S11. doi:10.1097/01.mlr.0000258615.42478.55
   PubMed Web of Science ®Google Scholar
• Mells GF, Pells G, Newton JL, et al. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology. 2013;58(1):273–283. doi:10.1002/hep.26365
   PubMed Web of Science ®Google Scholar
• Newton JL, Bhala N, Burt J, Jones DE. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol. 2006;44(4):776–783. doi:10.1016/j.jhep.2005.12.012
   PubMed Web of Science ®Google Scholar
• Ufere NN, Donlan J, Waldman L, et al. Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease. Clin Gastroenterol Hepatol. 2019;17(12):2592–2599. doi:10.1016/j.cgh.2019.03.022
   PubMed Web of Science ®Google Scholar
• Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169–180. doi:10.1007/BF00435221
   PubMed Web of Science ®Google Scholar
• Zoe T, Jane C, Rebecca H, Joe W, Guha IN, Morling JR. Health related quality of life in individuals at high risk of chronic liver disease: impact of a community diagnostic pathway. Public Health Pract. 2020;1:100033. doi:10.1016/j.puhip.2020.100033
   Google Scholar
• Health USDo, Human Services FDACfDE, Research. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79. doi:10.1186/1477-7525-4-79
   PubMed Web of Science ®Google Scholar
• Berg SK, Thorup CB, Borregaard B, et al. Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: findings from the national DenHeart survey. Eur J Prev Cardiol Apr. 2019;26(6):624–637. doi:10.1177/2047487318769766
   PubMed Web of Science ®Google Scholar
• Nagy KV, Merkely B, Rosero S, et al. Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients. Europace. 2019;21(12):1865–1875. doi:10.1093/europace/euz262
   PubMed Web of Science ®Google Scholar
• Pan CW, Liu RJ, Yang XJ, et al. Could the EQ-5D-3L predict all-cause mortality in older Chinese? Evidence from a 5-year longitudinal study in eastern China. Qual Life Res. 2021;30(10):2887–2894. doi:10.1007/s11136-021-02883-5
   PubMed Web of Science ®Google Scholar
• Phyo AZZ, Freak-Poli R, Craig H, et al. Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1596. doi:10.1186/s12889-020-09639-9
   PubMed Web of Science ®Google Scholar
• Cooper R, Kuh D, Hardy R, Mortality Review G, Falcon THAS. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010;341:c4467. doi:10.1136/bmj.c4467
   PubMed Web of Science ®Google Scholar
• Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S, Merli M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol. 2021;75(Suppl 1):S147–S162. doi:10.1016/j.jhep.2021.01.025
   PubMed Web of Science ®Google Scholar
• Hui Y, Cui B, Wang X, et al. The relationship between patient-reported health-related quality of life and malnutrition risk in cirrhosis: an observational cohort study. Br J Nutr. 2023;130(5):860–867. doi:10.1017/S0007114522003841
   PubMed Web of Science ®Google Scholar
• Shanavas N, Devadas K, Nahaz N, Varghese J, Cyriac R, Mathew D. Association of sarcopenia with health related quality of life in cirrhotics. J Assoc Physicians India. 2021;69(11):11–12.
   PubMedGoogle Scholar
• Sugiyama Y, Ishizu Y, Ando Y, et al. Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e916–e921. doi:10.1097/MEG.0000000000002303
   PubMedGoogle Scholar
• Masel MC, Ostir GV, Ottenbacher KJ. Frailty, mortality, and health-related quality of life in older Mexican Americans. J Am Geriatr Soc. 2010;58(11):2149–2153. doi:10.1111/j.1532-5415.2010.03146.x
   PubMed Web of Science ®Google Scholar